Increasing prevalence of premature births as well as malnourished child births, especially in under-developed countries, is a key factor driving market revenue growth.
Market Size - USD 6,018.4 Million in 2020, Market Growth - CAGR of 5.3%, Market Trends - Administering parenteral nutrition and monitoring patients remotely or at patient’s home. In addition, increasing use of parenteral nutrition of COVID-19 patients.
The global parenteral nutrition market size is expected to reach USD 9,158.7 Million in 2028, and register a CAGR of 5.3% during the forecast period. Market growth is majorly driven by factors such as growing population of malnourished human beings, particularly in underdeveloped countries, rising number of premature births, increasing prevalence of various chronic diseases such as cancer and autoimmune diseases are resulting in need for administration of parenteral nutrition to patients who are unable eat by mouth or via tube feeding. Thus, driving adoption of parenteral nutrition technique and driving market growth.
Growing geriatric population, and adoption of parenteral nutrition technique to administer vital nutrients to elderly people in order to provide and maintain hydration levels, energy, and strength is another major factor driving growth of the global parenteral nutrition market. These nutrients include proteins, essential fats and carbohydrates, minerals, electrolytes, vitamins, and vital trace elements.
Possible side effects of over-consuming parenteral nutrition such as changes in heart rate, rapid weight loss or gain, seizures, fatigue, fever, chills, frequent urination, as well as memory loss could hamper consumption of parenteral nutrition and restrain market growth.
Some Key Findings From the Report:
For the purpose of this report, the global parenteral nutrition market is segmented based on nutrient type, consumer type, end use, and region:
Nutrient Type Outlook
Consumer Type Outlook
End Use Outlook
Region Outlook
Reasons to Buy the Report
Market Size - USD 6,018.4 Million in 2020, Market Growth - CAGR of 5.3%, Market Trends - Administering parenteral nutrition and monitoring patients remotely or at patient’s home. In addition, increasing use of parenteral nutrition of COVID-19 patients.
The global parenteral nutrition market size is expected to reach USD 9,158.7 Million in 2028, and register a CAGR of 5.3% during the forecast period. Market growth is majorly driven by factors such as growing population of malnourished human beings, particularly in underdeveloped countries, rising number of premature births, increasing prevalence of various chronic diseases such as cancer and autoimmune diseases are resulting in need for administration of parenteral nutrition to patients who are unable eat by mouth or via tube feeding. Thus, driving adoption of parenteral nutrition technique and driving market growth.
Growing geriatric population, and adoption of parenteral nutrition technique to administer vital nutrients to elderly people in order to provide and maintain hydration levels, energy, and strength is another major factor driving growth of the global parenteral nutrition market. These nutrients include proteins, essential fats and carbohydrates, minerals, electrolytes, vitamins, and vital trace elements.
Possible side effects of over-consuming parenteral nutrition such as changes in heart rate, rapid weight loss or gain, seizures, fatigue, fever, chills, frequent urination, as well as memory loss could hamper consumption of parenteral nutrition and restrain market growth.
Some Key Findings From the Report:
- Among the nutrition type segments, the single dose amino acid solutions segment accounted for the largest revenue share in 2020, due to growing number of health-conscious people, and prevalence of various chronic diseases at a global level. The lipid emulsion segment is expected to register a robust revenue CAGR during the forecast period.
- Among the end-use segments, the hospital segment accounted for major revenue share in 2020, due to higher number of patient footfall in government or private hospitals as compared to other healthcare centers. The clinics segment is expected to register a robust revenue CAGR during the forecast period, owing to need for personal attention and care to be given to patients who need parenteral nutrition.
- The North America parenteral nutrition market accounted for major revenue share in 2020, owing to increasing investments in research and development by government in countries in the region, along with privately-owned healthcare organizations, and regulatory authorities for manufacturing parenteral nutrition drugs.
- The Asia Pacific market is expected to register a robust revenue CAGR during the forecast period.
- Companies considered and profiled in the market report include Baxter International Inc., Grifols International S.A., Actavis Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Hospira Inc., Claris Lifesciences Limited, Sichuan Kelun Pharmaceutical, Pfizer, and Aculife (Nirlife). The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
For the purpose of this report, the global parenteral nutrition market is segmented based on nutrient type, consumer type, end use, and region:
Nutrient Type Outlook
- Carbohydrates
- Lipid Emulsion
- Single Dose Amino Acid Solution
- Trace Elements
- Vitamins and Minerals
Consumer Type Outlook
- Children and New-born
- Adults
End Use Outlook
- Hospital
- Clinic
- Others
Region Outlook
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East and Africa
Reasons to Buy the Report
- A robust analysis and estimation of the Parenteral Nutrition Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
- A holistic competitive landscape of the all the major players in Parenteral Nutrition Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
- Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
- Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
- Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Table of Contents
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 3. Indicative Metrics
Chapter 4. Parenteral Nutrition Segmentation & Impact Analysis
Chapter 5. Parenteral Nutrition Market By Nutrient Type Insights & Trends
Chapter 6. Parenteral Nutrition Market By Consumer Type Insights & Trends
Chapter 7. Parenteral Nutrition Market By End Use Insights & Trends
Chapter 8. Parenteral Nutrition Market Regional Outlook
Chapter 9. Competitive Landscape
Chapter 10. Company Profiles
Companies Mentioned
- Baxter International Inc.
- Grifols International S.A.
- Actavis Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Hospira Inc.
- Claris Lifesciences Limited
- Sichuan Kelun Pharmaceutical
- Pfizer and Aculife (Nirlife)
